Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
0.612
+0.042 (7.30%)
At close: Dec 20, 2024, 4:00 PM
0.516
-0.096 (-15.71%)
After-hours: Dec 20, 2024, 7:59 PM EST
TNXP Employees
Tonix Pharmaceuticals Holding had 103 employees as of December 31, 2023. The number of employees decreased by 14 or -11.97% compared to the previous year.
Employees
103
Change (1Y)
-14
Growth (1Y)
-11.97%
Revenue / Employee
$109,621
Profits / Employee
-$1,313,107
Market Cap
114.30M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
American Well | 1,104 |
TELA Bio | 227 |
Cabaletta Bio | 103 |
PepGen | 64 |
Leap Therapeutics | 54 |
Milestone Pharmaceuticals | 47 |
Sensus Healthcare | 35 |
Cassava Sciences | 29 |
TNXP News
- 4 days ago - FDA accepts Tonix's NDA for non-opioid fibromyalgia drug TNX-102 SL - Invezz
- 4 days ago - Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia - GlobeNewsWire
- 5 days ago - Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights - GlobeNewsWire
- 12 days ago - Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers - Accesswire
- 25 days ago - Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference - GlobeNewsWire
- 4 weeks ago - Muscarinic Acetylcholine Receptor M1 Antagonists Pipeline Research Report 2024: Comprehensive Insights on 8+ Drugs Featuring Tonix Pharmaceuticals, BMS, WinSanTor, and Apnimed - GlobeNewsWire
- 4 weeks ago - Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual - GlobeNewsWire
- 5 weeks ago - Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments - Accesswire